Role of IL‐25, IL‐33, and TSLP in triggering united airway diseases toward type 2 inflammation

Citations Over TimeTop 10% of 2020 papers

Abstract

Under the concept of "united airway diseases," the airway is a single organ wherein upper and lower airway diseases are commonly comorbid. The upper and lower airways are lined with respiratory epithelium that plays a vital role in immune surveillance and modulation as the first line of defense to various infective pathogens, allergens, and physical insults. Recently, there is a common hypothesis emphasizing epithelium-derived cytokines, namely IL-25, IL-33, and TSLP, as key regulatory factors that link in immune-pathogenic mechanisms of allergic rhinitis (AR), chronic rhinosinusitis (CRS), and asthma, mainly involving in type 2 inflammatory responses and linking innate and adaptive immunities. Herein, we review studies that elucidated the role of epithelium-derived triple cytokines in both upper and lower airways with the purpose of expediting better clinical treatments and managements of AR, CRS, asthma, and other associated allergic diseases via applications of the modulators of these cytokines.

Related Papers

• → Differential global gene expression in cystic fibrosis nasal and bronchial epithelium(2011)66 cited
• → In vivomodels of human airway epithelium repair and regeneration(2005)34 cited
• → The pharmacology of the respiratory epithelium(1992)5 cited
• Apoptosis in normal bronchial respiratory epithelium between certainties and uncertainties(2010)
• → Innate immune response in airway epithelium fight against respiratory bacterial pathongens(2012)